Introduction
We are pleased to invite you to the webinar titled ‘JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations'. Where our speakers will be sharing their experience through clinical cases of RA and PsA. As well as, the latest long-term efficacy and safety related data.
Objectives
- Providing the data of approved JAK inhibitors in the management of Rheumatoid Arthritis and IL 17 in the management of Psoriatic Arthritis.
- Sharing clinical cases of RA and PsA.
- Safety and efficacy profile of JAK Inhibitor & IL17.
This Course For :
Physician
Resident / Fellow
Clinical Pharmacy
Sponsored by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
15 Mar 2021 To 15 Mar 2021 -
09:00 PM To 10:30 PM 
Certificate Available 
Online Click Here
- 551
- Premium
Add to Calendar
03/15/2021 09:00 PM
03/15/2021 10:30 PM
Asia/ Riyadh
JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations
JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations
https://medicalacademy.org/portal/event/view/1411
